医学
肾脏疾病
糖尿病
内科学
2型糖尿病
疾病
梅德林
重症监护医学
内分泌学
政治学
法学
作者
George L. Bakris,Rajiv Agarwal,Stefan D. Anker,Bertram Pitt,Luís M. Ruilope,Peter Rossing,Peter Kolkhof,Christina Nowack,Patrick Schloemer,Amer Joseph,Jingmei Li
标识
DOI:10.1056/nejmoa2025845
摘要
In patients with CKD and type 2 diabetes, treatment with finerenone resulted in lower risks of CKD progression and cardiovascular events than placebo. (Funded by Bayer; FIDELIO-DKD ClinicalTrials.gov number, NCT02540993.).
科研通智能强力驱动
Strongly Powered by AbleSci AI